Autophagy failure in Alzheimer’s disease and lysosomal storage disorders: A common pathway to neurodegeneration?

Autophagy of the Nervous System: Cellular Self-Digestion in Neurons and Neurological Diseases

Volumn , Issue , 2012, Pages 237-257

  Wolfe, Devin M ^a   Nixon, Ralph A ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84971325184     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814350457_0010     Document Type: Chapter

References (116)

1. S. U. Walkley, Cellular pathology of lysosomal storage disorders, Brain Pathol 8: 175-193 (1998).
2. L. B. Jardim, M. M. Villanueva, C. F. de Souza and C. B. Netto, Clinical aspects of neuropathic lysosomal storage disorders, J Inherit Metab Dis 33: 315-329 (2010).
3. W. J. Strittmatter and A. D. Roses, Apolipoprotein E and Alzheimer’s disease, Annu Rev Neurosci 19: 53-77 (1996).
4. M. L. Schultz, L. Tecedor, M. Chang and B. L. Davidson, Clarifying lysosomal storage diseases, Trends Neurosci 34: 401-410 (2011).
5. J. M. Weimer, E. Kriscenski-Perry, Y. Elshatory and D. A. Pearce, The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease, Neuromolecular Med 1: 111-124 (2002).
6. T. Hara, K. Nakamura, M. Matsui, A. Yamamoto, Y. Nakahara, R. Suzuki-Migishima, M. Yokoyama, K. Mishima, I. Saito, H. Okano and N. Mizushima, Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice, Nature 441: 885-889 (2006).
7. Y. Cao, J. A. Espinola, E. Fossale, A. C. Massey, A. M. Cuervo, M. E. MacDonald and S. L. Cotman, Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis, J Biol Chem 281: 20483-20493 (2006).
8. C. Curcio-Morelli, F. A. Charles, M. C. Micsenyi, Y. Cao, B. Venugopal, M. F. Browning, K. Dobrenis, S. L. Cotman, S. U. Walkley and S. A. Slaugenhaupt, Macroautophagy is defective in mucolipin-1-deficient mouse neurons, Neurobiol Dis 40: 370-377 (2010).
9. C. D. Pacheco, R. Kunkel and A. P. Lieberman, Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects, Hum Mol Genet 16: 1495-1503 (2007).
10. T. Fukuda, L. Ewan, M. Bauer, R. J. Mattaliano, K. Zaal, E. Ralston, P. H. Plotz and N. Raben, Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease, Ann Neurol 59: 700-708 (2006).
11. J. J. Jennings, Jr., J. H. Zhu, Y. Rbaibi, X. Luo, C. T. Chu and K. Kiselyov, Mitochondrial aberrations in mucolipidosis Type IV, J Biol Chem 281: 39041-39050 (2006).
12. D. S. Yang, A. Kumar, P. Stavrides, J. Peterson, C. M. Peterhoff, M. Pawlik, E. Levy, A. M. Cataldo and R. A. Nixon, Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer’s disease, Am J Pathol 173: 665-681 (2008).
13. N. Mizushima, Autophagy: process and function, Genes Dev 21: 2861-2873 (2007).
14. D. J. Klionsky and A. Nemchenko, There is more to autophagy than induction: regulating the roller coaster, Autophagy 7: 801-802 (2011).
15. B. Levine and G. Kroemer, Autophagy in the pathogenesis of disease, Cell 132: 27-42 (2008).
16. T. Shintani and D. J. Klionsky, Autophagy in health and disease: a double-edged sword, Science 306: 990-995 (2004).
17. J. Huang and D. J. Klionsky, Autophagy and human disease, Cell Cycle 6: 1837-1849 (2007).
18. Y. Gorzalczany, Y. Gilad, D. Amihai, I. Hammel, R. Sagi-Eisenberg and O. Merimsky, Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: a beneficial strategy to combat non-small cell lung cancer, Cancer Lett 310: 207-215 (2011).
19. J. Bove, M. Martinez-Vicente and M. Vila, Fighting neurodegeneration with rapamy-cin: mechanistic insights, Nat Rev Neurosci 12: 437-452 (2011).
20. A. Nemchenko, M. Chiong, A. Turer, S. Lavandero and J. A. Hill, Autophagy as a therapeutic target in cardiovascular disease, J Mol Cell Cardiol 51: 584-593 (2011).
21. M. Y. Heng, D. K. Duong, R. L. Albin, S. J. Tallaksen-Greene, J. M. Hunter, M. J. Lesort, A. Osmand, H. L. Paulson and P. J. Detloff, Early autophagic response in a novel knock-in model of Huntington disease, Hum Mol Genet 19: 3702-3720 (2010).
22. A. Alzheimer, H. Forstl and R. Levy, On certain peculiar diseases of old age, Hist Psychiatry 2: 71-101 (1991).
23. T. Simchowicz, Histologische Studien uber die senile Demenz. In: Histologie and Histopathologische Arbeiten uber die Grosshirnrinde, Vol. IV, eds. F. Nissl and A. Alzheimer (Fischer, Jena, 1911), pp. 267-444.
24. R. A. Nixon, J. Wegiel, A. Kumar, W. H. Yu, C. Peterhoff, A. Cataldo and A. M. Cuervo, Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study, J Neuropathol Exp Neurol 64: 113-122 (2005).
25. B. Boland, A. Kumar, S. Lee, F. M. Platt, J. Wegiel, W. H. Yu and R. A. Nixon, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease, J Neurosci 28: 6926-6937 (2008).
26. S. Y. Lee and R. A. Nixon, Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer’s-like neuritic dystrophy, Autophagy 7: 1562-1563 (2011).
27. U. Felbor, B. Kessler, W. Mothes, H. H. Goebel, H. L. Ploegh, R. T. Bronson and B. R. Olsen, Neuronal loss and brain atrophy in mice lacking cathepsins B and L, Proc Natl Acad Sci USA 99: 7883-7888 (2002).
28. M. Koike, M. Shibata, S. Waguri, K. Yoshimura, I. Tanida, E. Kominami, T. Gotow, C. Peters, K. von Figura, N. Mizushima, P. Saftig and Y. Uchiyama, Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease), Am J Pathol 167: 1713-1728 (2005).
29. S. Lee, Y. Sato and R. A. Nixon, Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer’s-like axonal dystrophy, J Neurosci 31: 7817-7830 (2011).
30. D. S. Yang, P. Stavrides, P. S. Mohan, S. Kaushik, A. Kumar, M. Ohno, S. D. Schmidt, D. Wesson, U. Bandyopadhyay, Y. Jiang, M. Pawlik, C. M. Peterhoff, A. J. Yang, D. A. Wilson, P. St George-Hyslop, D. Westaway, P. M. Mathews, E. Levy, A. M. Cuervo and R. A. Nixon, Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer’s disease ameliorates amyloid pathologies and memory deficits, Brain 134: 258-277 (2011).
31. D. Butler, J. Hwang, C. Estick, A. Nishiyama, S. S. Kumar, C. Baveghems, H. B. Young-Oxendine, M. L. Wisniewski, A. Charalambides and B. A. Bahr, Protective effects of positive lysosomal modulation in Alzheimer’s disease transgenic mouse models, PLoS One 6: e20501 (2011).
32. B. Sun, Y. Zhou, B. Halabisky, I. Lo, S. H. Cho, S. Mueller-Steiner, N. Devidze, X. Wang, A. Grubb and L. Gan, Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer’s disease, Neuron 60: 247-257 (2008).
33. J. H. Lee, W. H. Yu, A. Kumar, S. Lee, P. S. Mohan, C. M. Peterhoff, D. M. Wolfe, M. Martinez-Vicente, A. C. Massey, G. Sovak, Y. Uchiyama, D. Westaway, A. M. Cuervo and R. A. Nixon, Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations, Cell 141: 1146-1158 (2010).
34. L. Spokes, T. Jickells, K. Weston, B. G. Gustafsson, M. Johnsson, B. Liljebladh, D. Conley, C. Ambelas-Skjodth, J. Brandt, J. Carstensen, T. Christiansen, L. Frohn, G. Geernaert, O. Hertel, B. Jensen, C. Lundsgaard, S. Markager, W. Martinsen, B. Moller, B. Pedersen, K. Sauerberg, L. L. Sorensen, C. C. Hasager, A. M. Sempreviva, S. C. Pryor, S. W. Lund, S. Larsen, M. Tjernstrom, G. Svensson and M. Zagar, MEAD: an interdisciplinary study of the marine effects of atmospheric deposition in the Kattegat, Environ Pollut 140: 453-462 (2006).
35. D. Ling, H. J. Song, D. Garza, T. P. Neufeld and P. M. Salvaterra, Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila, PLoS One 4: e4201 (2009).
36. A. Williams, L. Jahreiss, S. Sarkar, S. Saiki, F. M. Menzies, B. Ravikumar and D. C. Rubinsztein, Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications, Curr Top Dev Biol 76: 89-101 (2006).
37. Z. Berger, B. Ravikumar, F. M. Menzies, L. G. Oroz, B. R. Underwood, M. N. Pangalos, I. Schmitt, U. Wullner, B. O. Evert, C. J. O’Kane and D. C. Rubinsztein, Rapamycin alleviates toxicity of different aggregate-prone proteins, Hum Mol Genet 15: 433-442 (2006).
38. S. Sarkar, J. E. Davies, Z. Huang, A. Tunnacliffe and D. C. Rubinsztein, Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein, J Biol Chem 282: 5641-5652 (2007).
39. P. Spilman, N. Podlutskaya, M. J. Hart, J. Debnath, O. Gorostiza, D. Bredesen, A. Richardson, R. Strong and V. Galvan, Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease, PLoS One 5: e9979 (2010).
40. W. H. Yu, A. M. Cuervo, A. Kumar, C. M. Peterhoff, S. D. Schmidt, J. H. Lee, P. S. Mohan, M. Mercken, M. R. Farmery, L. O. Tjernberg, Y. Jiang, K. Duff, Y. Uchiyama, J. Naslund, P. M. Mathews, A. M. Cataldo and R. A. Nixon, Macroautophagy — a novel Beta-amyloid peptide-generating pathway activated in Alzheimer’s disease, J Cell Biol 171: 87-98 (2005).
41. Y. Jiang, K. A. Mullaney, C. M. Peterhoff, S. Che, S. D. Schmidt, A. Boyer- Boiteau, S. D. Ginsberg, A. M. Cataldo, P. M. Mathews and R. A. Nixon, Alzheimer’s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition, Proc Natl Acad Sci USA 107: 1630-1635
42. A. M. Cataldo, J. L. Barnett, S. A. Berman, J. Li, S. Quarless, S. Bursztajn, C. Lippa and R. A. Nixon, Gene expression and cellular content of cathepsin D in Alzheimer’s disease brain: evidence for early up-regulation of the endosomal-lysosomal system, Neuron 14: 671-680 (1995).
43. Z. S. Ji, R. D. Miranda, Y. M. Newhouse, K. H. Weisgraber, Y. Huang and R. W. Mahley, Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells, J Biol Chem 277: 21821-21828 (2002).
44. J. C. Cossec, A. Simon, C. Marquer, R. X. Moldrich, C. Leterrier, J. Rossier, C. Duyckaerts, Z. Lenkei and M. C. Potier, Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol, Biochim Biophys Acta 1801: 846-852 (2010).
45. A. M. Cataldo, C. M. Peterhoff, J. C. Troncoso, T. Gomez-Isla, B. T. Hyman and R. A. Nixon, Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am J Pathol 157: 277-286 (2000).
46. A. J. Beel, C. K. Mobley, H. J. Kim, F. Tian, A. Hadziselimovic, B. Jap, J. H. Prestegard and C. R. Sanders, Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?, Biochemistry 47: 9428-9446 (2008).
47. A. M. Cataldo, P. M. Mathews, A. B. Boiteau, L. C. Hassinger, C. M. Peterhoff, Y. Jiang, K. Mullaney, R. L. Neve, J. Gruenberg and R. A. Nixon, Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects, Am J Pathol 173: 370-384 (2008).
48. C. M. Fader and M. I. Colombo, Autophagy and multivesicular bodies: two closely related partners, Cell Death Differ 16: 70-78 (2009).
49. P. B. Gordon and P. O. Seglen, Prelysosomal convergence of autophagic and endocytic pathways, Biochem Biophys Res Commun 151: 40-47 (1988).
50. R. A. Nixon and D. S. Yang, Autophagy failure in Alzheimer’s disease-locating the primary defect, Neurobiol Dis 43: 38-45 (2011).
51. R. A. Nixon and D. S. Yang, Autophagy failure in Alzheimer’s disease-locating the primary defect, Neurobiol Dis 43: 38-45 (2011).
52. S. I. Kim, W. K. Lee, S. S. Kang, S. Y. Lee, M. J. Jeong, H. J. Lee, S. S. Kim, G. V. Johnson and W. Chun, Suppression of autophagy and activation of glycogen synthase kinase 3beta facilitate the aggregate formation of tau, Korean J Physiol Pharmacol 15: 107-114 (2011).
53. A. Caccamo, S. Majumder, A. Richardson, R. Strong and S. Oddo, Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments, J Biol Chem 285: 13107-13120 (2010).
54. A. M. Cuervo, L. Stefanis, R. Fredenburg, P. T. Lansbury and D. Sulzer, Impaired degradation of mutant a-synuclein by chaperone-mediated autophagy, Science 305: 1292-1295 (2004).
55. P. O. Bauer, A. Goswami, H. K. Wong, M. Okuno, M. Kurosawa, M. Yamada, H. Miyazaki, G. Matsumoto, Y. Kino, Y. Nagai and N. Nukina, Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein, Nat Biotechnol 28: 256-263 (2010).
56. Y. Wang, J. C. Groppe, J. Wu, T. Ogawa, G. Mues, R. N. D’Souza and H. Kapadia, Pathogenic mechanisms of tooth agenesis linked to paired domain mutations in human PAX9, Hum Mol Genet 18: 2863-2874 (2009).
57. E. Arias and A. M. Cuervo, Chaperone-mediated autophagy in protein quality control, Curr Opin Cell Biol 23: 184-189 (2011).
58. Y. Wang, M. Martinez-Vicente, U. Kruger, S. Kaushik, E. Wong, E. M. Mandelkow, A. M. Cuervo and E. Mandelkow, Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing, Hum Mol Genet 18: 4153-4170 (2009).
59. A. Terman, B. Gustafsson and U. T. Brunk, Autophagy, organelles and ageing, J Pathol 211: 134-143 (2007).
60. D. S. Yang, J. H. Lee and R. A. Nixon, Monitoring autophagy in Alzheimer’s disease and related neurodegenerative diseases, Methods Enzymol 453: 111-144 (2009).
61. G. Kroemer and M. Jaattela, Lysosomes and autophagy in cell death control, Nat Rev Cancer 5: 886-897 (2005).
62. P. Syntichaki and N. Tavernarakis, The biochemistry of neuronal necrosis: rogue biology? Nat Rev Neurosci 4: 672-684 (2003).
63. K. E. Wisniewski, D. Maslinska, T. Kitaguchi, K. S. Kim, H. H. Goebel and M. Haltia, Topographic heterogeneity of amyloid P-protein epitopes in brains with various forms of neuronal ceroid lipofuscinoses suggesting defective processing of amyloid precursor protein, Acta Neuropathol 80: 26-34 (1990).
64. E. D. Carstea, J. A. Morris, K. G. Coleman, S. K. Loftus, et al., Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis, Science 277: 228-231 (1997).
65. Y. A. Ioannou, The structure and function of the Niemann-Pick C1 protein, Mol Genet Metab 71: 175-181 (2000).
66. L. Liscum, R. M. Ruggiero and J. R. Faust, The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts, J Cell Biol 108: 1625-1636 (1989).
67. D. te Vruchte, E. Lloyd-Evans, R. J. Veldman, D. C. Neville, R. A. Dwek, F. M. Platt, W. J. van Blitterswijk and D. J. Sillence, Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport, J Biol Chem 279: 26167-26175 (2004).
68. T. Yamamoto, H. Ninomiya, M. Matsumoto, Y. Ohta, E. Nanba, Y. Tsutsumi, K. Yamakawa, G. Millat, M. T. Vanier, P. G. Pentchev and K. Ohno, Genotype-phenotype relationship of Niemann-Pick disease type C: a possible correlation between clinical onset and levels of NPC1 protein in isolated skin fibroblasts, J Med Genet 37: 707-712 (2000).
69. M. T. Vanier and G. Millat, Niemann-Pick disease type C, Clin Genet 64: 269-281 (2003).
70. C. Xie, D. K. Burns, S. D. Turley and J. M. Dietschy, Cholesterol is sequestered in the brains of mice with Niemann-Pick type C disease but turnover is increased, J Neuropathol Exp Neurol 59: 1106-1117 (2000).
71. M. Zervas, K. Dobrenis and S. U. Walkley, Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations, J Neuropathol Exp Neurol 60: 49-64 (2001).
72. S. Takikita, T. Fukuda, I. Mohri, T. Yagi and K. Suzuki, Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse, J Neuropathol Exp Neurol 63: 660-673 (2004).
73. B. Bu, J. Li, P. Davies and I. Vincent, Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model, J Neurosci 22: 6515-6525 (2002).
74. D. C. German, E. M. Quintero, C. L. Liang, B. Ng, S. Punia, C. Xie and J. M. Dietschy, Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease, J Comp Neurol 433: 415-425 (2001).
75. C. D. Pacheco, M. J. Elrick and A. P. Lieberman, Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis, Hum Mol Genet 18: 956-965 (2009).
76. D. C. Ko, L. Milenkovic, S. M. Beier, H. Manuel, J. Buchanan and M. P. Scott, Cell-autonomous death of cerebellar Purkinje neurons with autophagy in Niemann-Pick type C disease, PLoS Genet 1: 81-95 (2005).
77. G. Liao, Y. Yao, J. Liu, Z. Yu, S. Cheung, A. Xie, X. Liang and X. Bi, Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npcl— mouse brain, Am J Pathol 171: 962-975 (2007).
78. A. Nunes, S. N. Pressey, J. D. Cooper and S. Soriano, Loss of amyloid precursor protein in a mouse model of Niemann-Pick type C disease exacerbates its phenotype and disrupts tau homeostasis, Neurobiol Dis 42: 349-359 (2011).
79. N. Mattsson, H. Zetterberg, S. Bianconi, N. M. Yanjanin, R. Fu, J. E. Mansson, F. D. Porter and K. Blennow, Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study, Neurology 76: 366-372 (2011).
80. Y. Saito, K. Suzuki, E. Nanba, T. Yamamoto, K. Ohno and S. Murayama, Niemann-Pick type C disease: accelerated neurofibrillary tangle formation and amyloid beta deposition associated with apolipoprotein E epsilon 4 homozygosity, Ann Neurol 52: 351-355 (2002).
81. C. R. Scherzer, K. Offe, M. Gearing, H. D. Rees, G. Fang, C. J. Heilman, C. Schaller, H. Bujo, A. I. Levey and J. J. Lah, Loss of apolipoprotein E receptor LR11 in Alzheimer disease, Arch Neurol 61: 1200-1205 (2004).
82. M. P. Marzolo and G. Bu, Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer’s disease, Semin Cell Dev Biol 20: 191-200 (2009).
83. L. W. Jin, F. S. Shie, I. Maezawa, I. Vincent and T. Bird, Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities, Am J Pathol 164: 975-985 (2004).
84. Z. S. Ji, K. Mullendorff, I. H. Cheng, R. D. Miranda, Y. Huang and R. W. Mahley, Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration, J Biol Chem 281: 2683-2692 (2006).
85. J. Ezaki and E. Kominami, The intracellular location and function of proteins of neuronal ceroid lipofuscinoses, Brain Pathol 14: 77-85 (2004).
86. H. H. Goebel, The neuronal ceroid-lipofuscinoses, J Child Neurol 10: 424-437 (1995).
87. H. M. Mitchison and S. E. Mole, Neurodegenerative disease: the neuronal ceroid lipofuscinoses (Batten disease), Curr Opin Neurol 14: 795-803 (2001).
88. J. M. Holopainen, J. Saarikoski, P. K. Kinnunen and I. Jarvela, Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs), Eur J Biochem 268: 5851-5856 (2001).
89. J. M. Weimer, J. W. Benedict, A. L. Getty, C. C. Pontikis, M. J. Lim, J. D. Cooper and D. A. Pearce, Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis, Brain Res 1266: 93-107 (2009).
90. D. N. Palmer, I. M. Fearnley, J. E. Walker, N. A. Hall, B. D. Lake, L. S. Wolfe, M. Haltia, R. D. Martinus and R. D. Jolly, Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease), Am J Med Genet 42: 561-567 (1992).
91. H. H. Goebel and K. E. Wisniewski, Current state of clinical and morphological features in human NCL, Brain Pathol 14: 61-69 (2004).
92. E. Fossale, P. Wolf, J. A. Espinola, T. Lubicz-Nawrocka, A. M. Teed, H. Gao, D. Rigamonti, E. Cattaneo, M. E. MacDonald and S. L. Cotman, Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis, BMC Neurosci 5: 57 (2004).
93. D. A. Pearce, S. A. Nosel and F. Sherman, Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p, Mol Genet Metab 66: 320-323 (1999).
94. S. Vergarajauregui, P. S. Connelly, M. P. Daniels and R. Puertollano, Autophagic dysfunction in mucolipidosis type IV patients, Hum Mol Genet 17: 2723-2737 (2008).
95. T. Otomo, K. Higaki, E. Nanba, K. Ozono and N. Sakai, Inhibition of autophagosome formation restores mitochondrial function in mucolipidosis II and III skin fibroblasts, Mol Genet Metab 98: 393-399 (2009).
96. A. Takamura, K. Higaki, K. Kajimaki, S. Otsuka, H. Ninomiya, J. Matsuda, K. Ohno, Y. Suzuki and E. Nanba, Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis, Biochem Biophys Res Commun 367: 616-622 (2008).
97. M. Manzoni, E. Monti, R. Bresciani, A. Bozzato, S. Barlati, M. T. Bassi and G. Borsani, Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization, FEBS Lett 567: 219-224 (2004).
98. P. R. Pryor, F. Reimann, F. M. Gribble and J. P. Luzio, Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic, Traffic 7: 1388-1398 (2006).
99. S. Vergarajauregui and R. Puertollano, Two di-leucine motifs regulate trafficking of mucolipin-1 to lysosomes, Traffic 7: 337-353 (2006).
100. G. Bach, Mucolipidosis type IV, Mol Genet Metab 73: 197-203 (2001).
101. J. M. LaPlante, C. P. Ye, S. J. Quinn, E. Goldin, E. M. Brown, S. A. Slaugenhaupt and P. M. Vassilev, Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV, Biochem Biophys Res Commun 322: 1384-1391 (2004).
102. H. F. Cantiello, N. Montalbetti, W. H. Goldmann, M. K. Raychowdhury, S. Gonzalez-Perrett, G. A. Timpanaro and B. Chasan, Cation channel activity of muco-lipin-1: the effect of calcium, Pflugers Archiv 451: 304-312 (2005).
103. A. A. Soyombo, S. Tjon-Kon-Sang, Y. Rbaibi, E. Bashllari, J. Bisceglia, S. Muallem and K. Kiselyov, TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity, JBiol Chem 281: 7294-7301 (2006).
104. G. Bach, M. M. Cohen and G. Kohn, Abnormal ganglioside accumulation in cultured fibroblasts from patients with mucolipidosis IV, Biochem Biophys Res Commun 66: 1483-1490 (1975).
105. B. F. Crandall, M. Philippart, W. J. Brown and D. A. Bluestone, Review article: mucolipidosis IV, Am JMed Genet 12: 301-308 (1982).
106. K. Venkatachalam, A. A. Long, R. Elsaesser, D. Nikolaeva, K. Broadie and C. Montell, Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells, Cell 135: 838-851 (2008).
107. M1-gangliosidosis and Morquio B disease. In: The Online Metabolic and Molecular Bases of Inherited Disease, eds. D.Valle, A. L. Beaudet, B. Vogelstein, K. W. Kinzler, et al. (McGraw-Hill, New York, 2007).
108. K. Suzuki and G. C. Chen, Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis), J Neuropathol Exp Neurol 27: 15-38 (1968).
109. J. P. van der Voorn, W. Kamphorst, M. S. van der Knaap and J. M. Powers, The leukoencephalopathy of infantile GM1 gangliosidosis: oligodendrocytic loss and axonal dysfunction, Acta Neuropathol 107: 539-545 (2004).
110. L. Svennerholm, Ganglioside loss is a primary event in Alzheimer disease type I, Progr Brain Res 101: 391-404 (1994).
111. I. Kracun, S. Kalanj, C. Cosovic and J. Talan-Hranilovic, Brain gangliosides in Alzheimer’s disease, J Hirnforsch 31: 789-793 (1990).
112. S. Kalanj, I. Kracun, H. Rosner and C. Cosovic, Regional distribution of brain gangliosides in Alzheimer’s disease, Neurol Croat 40: 269-281 (1991).
113. I. Y. Tamboli, H. Hampel, N. T. Tien, K. Tolksdorf, B. Breiden, P. M. Mathews, P. Saftig, K. Sandhoff and J. Walter, Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Abeta generation, J Neurosci 31: 1837-1849 (2011).
114. S. U. Walkley and K. Suzuki, Consequences of NPC1 and NPC2 loss of function in mammalian neurons, Biochim Biophys Acta 1685: 48-62 (2004).
115. S. U. Walkley, H. J. Baker, M. C. Rattazzi, M. E. Haskins and J. Y. Wu, Neuroaxonal dystrophy in neuronal storage disorders: evidence for major GABAergic neuron involvement, J Neurol Sci 104: 1-8 (1991).
116. S. D. Ginsberg, J. E. Galvin, V. M. Lee, L. B. Rorke, D. W. Dickson, J. H. Wolfe, M. Z. Jones and J. Q. Trojanowski, Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains, J Neuropathol Exp Neurol 58: 815-824 (1999).